Insys Therapeutics (INSY) Misses Q1 EPS by 1c
Tweet
Share
E-mail
Get Alerts INSY Hot Sheet
Join SI Premium – FREE
Insys Therapeutics (NASDAQ: INSY) reported Q1 EPS of ($0.19), $0.01 worse than the analyst estimate of ($0.18). Revenue for the quarter came in at $23.9 million versus the consensus estimate of $25.66 million.
For earnings history and earnings-related data on Insys Therapeutics (INSY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Schlumberger (SLB) earnings in-line, revenue beats expectations
- Parke Bancorp (PKBK) Reports Q1 EPS of $0.51
- Lakeland Bancorp (LBAI) Tops Q1 EPS by 1c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
